Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026 Psychedelics Investing
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities Life Science Investing
Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update Life Science Investing
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial Life Science Investing
Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories Life Science Investing
Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries Medical Device Investing
